Tagged with: Events 21 total views, 1 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis Jessops launches Click for Clic campaign Photographic retailer Jessops aims to raise at least £50,000 this year for CLIC – Cancer and Leukaemia in Childhood.Jessops launched the campaign by supporting CLIC’s Win a day off work fundraising day on 12 December 2003 in which companies donate extra days holiday to raffle off amongst staff to raise funds. A Pyjama Party Event was held on the day for 500 staff at Jessops Head office in Leicester. The company has already presented the charity with a £5,000 cheque.Jessops is planning further fundraising events both for employees and customers, and will be selling CLIC merchandise through its network of over 250 stores. Advertisement Howard Lake | 7 January 2004 | News About Howard Lake Howard Lake is a digital fundraising entrepreneur. Publisher of UK Fundraising, the world’s first web resource for professional fundraisers, since 1994. Trainer and consultant in digital fundraising. Founder of Fundraising Camp and co-founder of GoodJobs.org.uk. Researching massive growth in giving. AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis Jessops’ fundraising include news of the appeal – including a ‘CLIC-ometer’ to report on the appeal’s fundraising total – on its Web site.
Coordinating Economic Minister Airlangga Hartanto announced that the government had earmarked Rp 3.8 trillion for the down payment for purchasing COVID-19 vaccine.”One of our top priority programs for next year is COVID-19 vaccine procurement. This year we have allocated Rp 3.7 trillion for the vaccine,” Airlangga said in an online presser on Monday.”Next year we plan to set aside Rp 37 trillion for a multi-year program,” he added.Airlangga explained that the government was eyeing several potential vaccines that were currently under development.The first is the Merah Putih vaccine, which is being developed by the Research and Technology Ministry and the Eijkman Institute for Molecular Biology.Read also: Indonesia needs greater healthcare budget in 2021 for vaccine: EconomistThe second is the vaccine being developed by state pharmaceutical holding company PT Bio Farma in cooperation with Sinovac Biotech of China. The third vaccine is the one being developed by United Arab Emirates’ Group 42 (G42) Healthcare.”We plan to procure 290 million doses of the Sinovac vaccine next year and 30 million doses of the G42 vaccine this year,” Airlangga said.He explained that the Health Ministry was set to prepare the vaccination process, which is expected to start early next year.”With the procurement of 30 million doses of [G42] vaccine by the end of this year, we hope to start the vaccination process early next year,” he said.PT Bio Farma and Sinovac along with Padjadjaran University (Unpad) in Bandung, West Java are launching phase III clinical trials for a COVID-19 vaccine — the last stage of clinical testing in humans during which the vaccine is given to thousands of people to confirm and expand results on safety and efficacy from phase I and II trials — along with several countries such as Brazil and Bangladesh.Read also: WHO tempers quick vaccine hopesThe Sinovac phase III clinical trials in Bandung are to run for six months.The government has also given Eijkman 12 months starting from April to develop vaccine prototypes that have been tested on animals, to be given to Bio Farma for clinical trials. Bio Farma aims to mass-produce the vaccine by 2022 after earning approval from the BPOM. The Merah Putih vaccine is expected to cover at least 50 percent of Indonesia’s vaccine needs, given the country’s large population.Topics :
The 27-year-old Scotland international, who has missed the last four games, will sit out against Everton on Saturday and is likely to play no further part in the club’s fight for Barclays Premier League survival. Manager Gus Poyet is otherwise remaining coy over a series of minor knocks, but goalkeeper Keiren Westwood is still sidelined by a shoulder problem. Sunderland striker Steven Fletcher is unlikely to play again this season because of his ankle injury. The 32-year-old had to have five stitches in an eye wound early in last weekend’s victory over Arsenal. Defender Phil Jagielka (hamstring) could be fit to return for next weekend’s visit of Manchester United. Boss Roberto Martinez believes fighting for a place in the top four is no different from a relegation battle as the requirements are essentially identical. “I think it is exactly the same, if I am completely honest,” he said. “It is being able to focus on the game itself, understanding the intensity and the focus you need in every action. “In every season, whatever you are playing for, it comes down to the final points you are playing for: whether it is for staying in the league, making the top four or winning the title it is exactly the same. “Looking back at other seasons with Wigan, we managed to get seven wins out of the last nine and that is the same intensity you need to have in any aim you are fighting for.” Press Association Poyet has told his players to be brave as they attempt to escape the drop. The Black Cats slumped to the foot of the table after a disastrous few days last weekend which saw Fulham, West Brom and Crystal Palace all win before they were thrashed 5-1 at Tottenham on Monday evening. Poyet’s men are now seven points adrift of safety and knowing their two games in hand will count for little if they do not manufacture a significant improvement in form. The 46-year-old Uruguayan admitted after the debacle at White Hart Lane that his side would need a miracle to stay up, and had called upon his players to stand up and be counted in the club’s hour of need. Poyet said: “We try, we try to be brave. We have played games away from home against top teams and we have left one up front and we did okay; against Liverpool, we left two all the time and we did better; and against Spurs, we left two and we were terrible. “That shows you that it doesn’t matter too much sometimes, all the plans and all the things because it depends what happens on the pitch in 90 minutes, how we cope with situations, how we pass the ball, how we defend. “But maybe that word, being ‘brave’ is one of the biggest ones in this situation.” Midfielder Leon Osman is Everton’s only doubt.